Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
4.200
+0.110 (2.69%)
Apr 29, 2026, 3:14 PM CST

SHE:300267 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
976.83897.4698.54744.35764.67761.56
Trading Asset Securities
90901200.12114.12-
Cash & Short-Term Investments
1,067987.4818.54744.47878.79761.56
Cash Growth
51.10%20.63%9.95%-15.28%15.39%-40.90%
Accounts Receivable
202.12202.39198.3177.8204.48274.36
Other Receivables
3.533.624.4618.1727.8113.57
Receivables
205.65206.02202.77195.97232.29287.93
Inventory
523.93512600.78691.6821.34714.77
Prepaid Expenses
---1.39--
Other Current Assets
122.7383.159597.58158.78182.1
Total Current Assets
1,9191,7891,7171,7312,0911,946
Property, Plant & Equipment
2,3842,4252,7162,9172,8572,604
Long-Term Investments
99.7599.8121.74170.23188.97196.16
Goodwill
222210.0110.01
Other Intangible Assets
312.64317.12363.56378.03406.14431.45
Long-Term Deferred Tax Assets
119.8120.4150.55152.14168.92118.34
Long-Term Deferred Charges
8.899.5610.6612.0819.516.51
Other Long-Term Assets
112.9198.25117.78116.25114.6108.75
Total Assets
4,9594,8615,2005,4795,8565,432
Accounts Payable
113.47121.07114.66122.3198.7137.87
Accrued Expenses
12.4125.0126.0931.2223.3833.79
Short-Term Debt
684.51551.38488.2341.89396.64246
Current Portion of Long-Term Debt
4.828.79----
Current Portion of Leases
--3.692.164.113.88
Current Income Taxes Payable
3.148.750.170.990.970.74
Current Unearned Revenue
39.5426.1729.8247.0151.3137.35
Other Current Liabilities
59.0161.5642.7157.7350.3339.3
Total Current Liabilities
916.91802.73705.34603.3725.43498.93
Long-Term Leases
27.7227.8617.381.172.582.15
Long-Term Unearned Revenue
9.210.0614.9318.3923.1527.91
Long-Term Deferred Tax Liabilities
46.3546.3246.946.253.4129.29
Other Long-Term Liabilities
--12.99---
Total Liabilities
1,000886.97797.54669.05804.57558.28
Common Stock
2,0632,0632,0632,0632,0632,063
Additional Paid-In Capital
1,0191,0191,0191,0191,005998.96
Retained Earnings
937.38924.271,3041,6771,9351,889
Comprehensive Income & Other
2.7327.9561.2776.5248.34-99.15
Total Common Equity
4,0224,0344,4474,8365,0514,851
Minority Interest
-62.86-60.24-45.23-26.030.2722.49
Shareholders' Equity
3,9593,9744,4024,8105,0514,874
Total Liabilities & Equity
4,9594,8615,2005,4795,8565,432
Total Debt
717.05588.03509.27345.21403.33252.04
Net Cash (Debt)
349.79399.38309.27399.25475.46509.53
Net Cash Growth
23.16%29.13%-22.54%-16.03%-6.69%-38.28%
Net Cash Per Share
0.170.190.150.190.230.25
Filing Date Shares Outstanding
2,0482,0692,0632,0632,0632,063
Total Common Shares Outstanding
2,0482,0692,0632,0632,0632,063
Working Capital
1,002985.841,0121,1281,3661,447
Book Value Per Share
1.961.952.162.342.452.35
Tangible Book Value
3,7083,7154,0824,4564,6354,410
Tangible Book Value Per Share
1.811.801.982.162.252.14
Buildings
--1,9331,9901,9261,740
Machinery
--1,9141,8781,8961,224
Construction In Progress
--174.58220.8952.92506.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.